Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Glycemic Control in Patients with Employer-Sponsored Health Benefits

Glycemic Control in Patients with Employer-Sponsored Health Benefits

Authors: Louie JZ, Rowland CM, Shiffman D, Garg R, Bernal-Mizrachi E, McPhaul MJ

Citation: Popul Health Manag. 2025 Feb 17;28(1):8-14. doi:10.1089/pop.2024.0144

Specialties: Cardiology, Endocrinology, Population Health

Download key summary

Related content

Publication
Predictors of lack of glycemic control in persons with type 2 diabetes
Audio Podcast
Instant Insight: Metabolic Risk Panel
Audio Podcast
Commitment to Employee Health: A Blueprint for Wellness
Conference Presentation
Impact of Goal Setting in a Digital Health Coaching Program for Participants with Type 2 Diabetes
Conference Presentation
Effect of Digital Health Coaching on Healthy Eating in Individuals with Cardiometabolic Conditions
Conference Presentation
Measures of Insulin Resistance (IR) Increase with Increasing BMI in a Population of Normoglycemic Working Adults

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.